MY159072A - Probiotics to increase iga secretion in infants born by caesarean section - Google Patents

Probiotics to increase iga secretion in infants born by caesarean section

Info

Publication number
MY159072A
MY159072A MYPI2011000214A MYPI2011000214A MY159072A MY 159072 A MY159072 A MY 159072A MY PI2011000214 A MYPI2011000214 A MY PI2011000214A MY PI2011000214 A MYPI2011000214 A MY PI2011000214A MY 159072 A MY159072 A MY 159072A
Authority
MY
Malaysia
Prior art keywords
probiotics
caesarean section
iga secretion
infants born
increase iga
Prior art date
Application number
MYPI2011000214A
Inventor
Florence Rochat
Marie-Claire Fichot
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39769543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY159072(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MY159072A publication Critical patent/MY159072A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

USE OF PROBIOTIC BACTERIA IN THE MANUFACTURE OF A MEDICAMENT OR THERAPEUTIC NUTRITIONAL COMPOSITION FOR INCREASING IGA SECRETION IN AN INFANT DELIVERED BY CAESAREAN SECTION DURING THE FIRST FOUR MONTHS OF THE LIFE OF THE INFANT.
MYPI2011000214A 2008-07-21 2009-07-15 Probiotics to increase iga secretion in infants born by caesarean section MY159072A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08160806A EP2147678A1 (en) 2008-07-21 2008-07-21 Probiotics to increase IgA secretion in infants born by caesarean section

Publications (1)

Publication Number Publication Date
MY159072A true MY159072A (en) 2016-12-15

Family

ID=39769543

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2011000214A MY159072A (en) 2008-07-21 2009-07-15 Probiotics to increase iga secretion in infants born by caesarean section

Country Status (15)

Country Link
US (1) US9060540B2 (en)
EP (2) EP2147678A1 (en)
CN (1) CN102159226B (en)
AU (1) AU2009273331B2 (en)
BR (1) BRPI0916275A2 (en)
CA (1) CA2731541A1 (en)
CL (1) CL2011000146A1 (en)
ES (1) ES2442344T3 (en)
MX (1) MX2011000737A (en)
MY (1) MY159072A (en)
PL (1) PL2315595T3 (en)
PT (1) PT2315595E (en)
RU (1) RU2496505C2 (en)
WO (1) WO2010010021A1 (en)
ZA (1) ZA201101336B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012009315A2 (en) * 2010-07-12 2012-01-19 The Regents Of The University Of California Bovine milk oligosaccharides
EP2734049B1 (en) 2011-06-20 2018-05-02 H.J. Heinz Company Brands LLC Probiotic compositions and methods
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
WO2013117235A1 (en) * 2012-02-10 2013-08-15 N.V. Nutricia Maternal supplement to enhance immune system of an infant
NZ714202A (en) 2013-05-10 2021-07-30 Heinz Co Brands H J Llc Probiotics and methods of use
RU2016129426A (en) * 2013-12-19 2018-01-24 Нестек С.А. NUTRITIONAL COMPOSITION FOR REDUCING METABOLIC STRESS IN INFANTS
MX2016009038A (en) 2014-01-10 2017-02-08 Nestec Sa Maternal vitamin b12 administration for the prevention of increased adiposity, overweight or obesity in the offspring especially offspring overweight and/or obese mothers.
BR112016014700B1 (en) * 2014-01-10 2020-11-10 Société Des Produits Nestlé S.A uses of vitamin b6, and maternal food composition
ES2882496T3 (en) * 2014-03-21 2021-12-02 Nestle Sa Maternal administration of vitamin B2 to prevent an increase in adiposity, overweight or obesity of the child
EP3145520A2 (en) * 2014-05-20 2017-03-29 Biogaia AB Neonatal microbiome supplementation
CN104206539A (en) * 2014-08-14 2014-12-17 澳优乳业（中国）有限公司 Probiotic-containing infant milk powder
EP3212208B1 (en) * 2014-10-29 2021-03-03 Biogaia AB Use of l. reuteri for prevention or treatment of microbiota dysbiosis in early life
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
ES2879985T3 (en) * 2015-08-04 2021-11-23 Nestle Sa Nutritional compositions and infant formulas comprising Bifidobacterium animalis ssp. lactis and optionally a mixture of oligosaccharides to induce a gut microbiota close to that of breastfed babies
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
EP3397076A1 (en) 2015-12-29 2018-11-07 N.V. Nutricia Fermented formula with non-digestible oligosaccharides
CN108697141A (en) * 2015-12-29 2018-10-23 N·V·努特里奇亚 Nutritional formula containing non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
BR112019020443A2 (en) * 2017-05-05 2020-04-28 Nestle Sa colic treatment in babies
EP3812452A4 (en) * 2018-09-30 2021-11-03 Inner Mongolia Yili Industrial Group Co., Ltd. BIFIDOBACTERIUM LACTIS BL-99 AND ITS USES
CN114540245B (en) * 2022-03-17 2023-11-28 江南大学 Lactobacillus rhamnosus CCFM1228 with depression emotion relieving and intestinal tract secretion IgA promoting functions and application thereof
CN114540247B (en) * 2022-03-17 2023-11-28 江南大学 Lactobacillus fermentum CCFM1226 capable of improving intestinal IgA level and relieving enteritis and application thereof
CN114517171B (en) * 2022-03-17 2023-11-28 江南大学 A strain of Lactobacillus fermentum CCFM1225 that can promote intestinal secretion of IgA and its application

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
EP0577903B1 (en) 1992-07-06 1997-12-17 Societe Des Produits Nestle S.A. Agent antigastrite contenant lactobacillus acidophilus
EP0768375B2 (en) 1992-07-06 2002-06-12 Societe Des Produits Nestle S.A. Lactic bacteria
FI104465B (en) 1995-06-14 2000-02-15 Valio Oy Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use
EP1034787A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus strains preventing diarrhea caused by pathogenic bacteria
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
ES2326481T3 (en) * 2003-06-23 2009-10-13 Nestec S.A. FORMULA FOR NEWBORN OR CONTINUATION FORM.
KR101234435B1 (en) * 2005-02-02 2013-02-18 가부시키가이샤 메이지 Composition for immunostimulation
WO2006108824A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
CA2644968A1 (en) * 2006-03-07 2007-09-13 Nestec S.A. Synbiotic mixture
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota

Also Published As

Publication number Publication date
ES2442344T3 (en) 2014-02-11
CA2731541A1 (en) 2010-01-28
EP2315595A1 (en) 2011-05-04
PT2315595E (en) 2013-11-25
AU2009273331A1 (en) 2010-01-28
WO2010010021A1 (en) 2010-01-28
US9060540B2 (en) 2015-06-23
PL2315595T3 (en) 2014-04-30
BRPI0916275A2 (en) 2015-11-10
AU2009273331B2 (en) 2014-12-04
EP2147678A1 (en) 2010-01-27
MX2011000737A (en) 2011-02-24
CL2011000146A1 (en) 2011-06-17
US20110129452A1 (en) 2011-06-02
RU2011106319A (en) 2012-08-27
RU2496505C2 (en) 2013-10-27
ZA201101336B (en) 2012-07-25
CN102159226A (en) 2011-08-17
EP2315595B1 (en) 2013-11-06
CN102159226B (en) 2014-02-26

Similar Documents

Publication Publication Date Title
MY159072A (en) Probiotics to increase iga secretion in infants born by caesarean section
MX2009009931A (en) Probiotics to reduce development of allergy in infants born by caesarean section.
MX2009009670A (en) Reduction of risk of diarrhoea.
PH12014501749B1 (en) A nutritional composition comprising probiotics and improving sleep patterns
MY158816A (en) Probiotics for reduction of risk of obesity
NZ613165A (en) Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX2010005132A (en) Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates.
IN2012DN00878A (en)
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
MX2011012063A (en) Infant and young children feeding formula comprising probiotics for infants and young children.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY196432A (en) Methods Of Using Human Milk Oligosaccharides For Improving Airway Respiratory Health
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
PH12014500185A1 (en) Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX347403B (en) Anti-regurgitation and/or anti-gastrooesophageal reflux composition, preparation and uses.
MX2010002978A (en) Nutritional formulation with high energy content.
MY146018A (en) Method for improved breast milk feeding to reduce the risk of allergy
UA33597U (en) Method for prevention and correction of disbiotic states in newborn infants, born in mothers with herpesvirus infection
TH144912A (en) Reducing the risk of developing diarrhea
PH12013501388A1 (en) Methods of using human milk oligosaccharides for improving airway respiratory health